Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy Idera Pharmaceuticals stock
Learn how to easily invest in Idera Pharmaceuticals stock.
Idera Pharmaceuticals is a biotechnology business based in the US. Idera Pharmaceuticals shares (IDRA) are listed on the NASDAQ and all prices are listed in US Dollars. Idera Pharmaceuticals employs 13 staff and has a trailing 12-month revenue of around $49,000.
How to buy Idera Pharmaceuticals stock
- Open a stock trading account. Use our comparison table or choose from our Top Picks.
- Confirm your payment details. Fund your account with a bank transfer, debit card or credit card and take advantage of any signup bonuses.
- Search for the stock by name or ticker symbol – IDRA. It's that simple.
- Trade stocks for $0 and no annual fee
- Start trading with a $0 minimum deposit
- Get up to $1,000 when you fund a new account within 30 days
- Commission-free trading
- Commission-free crypto
- No minimum account balance
- $0 commissions on stocks and ETFs
- $0 closing commissions on stock and ETF options
- Get $200 in US stocks when you open and fund an account with min. $2,000 for 3+ mos.
Idera Pharmaceuticals stock price (NASDAQ: IDRA)Use our graph to track the performance of IDRA stocks over time.
Idera Pharmaceuticals shares at a glance
|Latest market close||$7.23|
|52-week range||$0.22 - $9.52|
|50-day moving average||$6.20|
|200-day moving average||$7.34|
|Wall St. target price||$1.00|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$-0.44|
Buy Idera Pharmaceuticals stocks from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
Information on this page is for educational purposes only. Finder is not an advisor or brokerage service, and we don't recommend investors to trade specific stocks or other investments.
Finder is not a client of any featured partner. We may be paid a fee for referring prospective clients to a partner, though it is not a recommendation to invest in any one partner.
Is it a good time to buy Idera Pharmaceuticals stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Idera Pharmaceuticals price performance over time
|1 week (2023-01-20)||38.68%|
|1 month (2022-12-27)||3,041.30%|
|3 months (2022-10-27)||1,752.56%|
|6 months (2022-07-27)||1,653.64%|
|1 year (2022-01-27)||1,211.25%|
|2 years (2021-01-27)||33.55%|
|3 years (2020-01-27)||308.19%|
|5 years (2018-01-26)||285.97%|
Idera Pharmaceuticals financials
|Gross profit TTM||$-9,247,000|
|Return on assets TTM||-15.19%|
|Return on equity TTM||-32.32%|
|Market capitalisation||$26.5 million|
TTM: trailing 12 months
Idera Pharmaceuticals share dividends
We're not expecting Idera Pharmaceuticals to pay a dividend over the next 12 months.
Have Idera Pharmaceuticals's shares ever split?
Idera Pharmaceuticals's shares were split on a 1:17 basis on 17 January 2023. So if you had owned 17 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Idera Pharmaceuticals shares – just the quantity. However, indirectly, the new 1600% higher share price could have impacted the market appetite for Idera Pharmaceuticals shares which in turn could have impacted Idera Pharmaceuticals's share price.
Idera Pharmaceuticals share price volatility
Over the last 12 months, Idera Pharmaceuticals's shares have ranged in value from as little as $0.215 up to $9.5209. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Idera Pharmaceuticals's is 1.2979. This would suggest that Idera Pharmaceuticals's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Idera Pharmaceuticals overview
Idera Pharmaceuticals, Inc. , a biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for rare disease indications in the United States. It offers Tilsotolimod (IMO-2125), a synthetic phosphorothioate oligonucleotide that acts as a direct agonist of TLR9 to stimulate the immune systems and for treating solid tumors, squamous cell carcinoma of the head and neck, and colorectal cancer. The company has a collaboration agreement with Bristol-Meyers Squibb. Idera Pharmaceuticals, Inc. was incorporated in 1989 and is headquartered in Exton, Pennsylvania. .
Idera Pharmaceuticals in the news
Idera Pharmaceuticals Announces Name Change to Aceragen, Inc. and Provides Near-Term Strategic Outlook
Frequently asked questionsWhat percentage of Idera Pharmaceuticals is owned by insiders or institutions?
Currently 29.559% of Idera Pharmaceuticals shares are held by insiders and 5.522% by institutions. How many people work for Idera Pharmaceuticals?
Latest data suggests 13 work at Idera Pharmaceuticals. When does the fiscal year end for Idera Pharmaceuticals?
Idera Pharmaceuticals's fiscal year ends in December. Where is Idera Pharmaceuticals based?
Idera Pharmaceuticals's address is: 505 Eagleview Boulevard, Exton, PA, United States, 19341 What is Idera Pharmaceuticals's ISIN number?
Idera Pharmaceuticals's international securities identification number is: US45168K4058 What is Idera Pharmaceuticals's CUSIP number?
Idera Pharmaceuticals's Committee on Uniform Securities Identification Procedures number is: 44860M108
More guides on Finder
How to buy TXO Energy (TXO) stock when it goes public
Everything we know about the TXO Energy IPO, plus information on how to buy in.
How to buy Brera (BREA) stock when it goes public
Everything we know about the Brera IPO, plus information on how to buy in.
How to invest in the S&P 500
What you need to know about investing in the leading indicator for the overall US stock market.
How to buy IPO stock
Buying an IPO is as simple as buying any other stock, but not every trading platform offers IPO stocks.
How to buy Novo Integrated Sciences stock
Steps to owning and managing NVOS, with 24-hour and historical pricing before you buy.
How do ETFs work?
Your simple and straightforward guide to ETFs, how they work and the different types available.
What is stock lending?
Find out how stock lending works, the extra income you could potentially earn and the risks you should be aware of. Plus, compare stock trading platforms that offer stock lending.
How to buy SONDORS (SODR) stock when it goes public
Everything we know about the SONDORS IPO, plus information on how to buy in.
How to buy Bullfrog AI Holdings (BFRG) stock when it goes public
Everything we know about the Bullfrog AI Holdings IPO, plus information on how to buy in.
How to research stocks
Learn about stock analysis and how to use it to find the right company to buy.
Ask an Expert